LB Pharmaceuticals

Public

New York City, New YorkBiotechhttps://www.lbpharma.us

Last Round

IPO Announced

Sep 10, 2025

Est. Valuation

$336M

Total Funding Raised

$378.9M

Company Overview

LB Pharmaceuticals is a biotechnology company focused on developing innovative treatments for schizophrenia, utilizing a pro-drug approach to enhance the efficacy and safety of amisulpride for improved patient outcomes.

Sector

Biotech

AI Layer

Non-AI

Keywords

schizophrenia treatmentLB-102clinical-stage biotechneuropsychiatric therapiesCNS therapeuticssmall molecule drugantipsychotic drugbenzamide antipsychoticdopamine D2 antagonistserotonin 5-HT7 antagonistnew chemical entityNCElate-stage clinical triallong-acting injectableLAImajor depressive disorderMDDbiotech IPO

LB Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

LB Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LB Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Sep 10, 2025
Series C	Jan 24, 2024
Series B	Sep 25, 2020
Series A	Mar 4, 2019
Seed	Apr 1, 2017

View all Funding Rounds

LB Pharmaceuticals Investors

Notable investors and investment history

LB Pharmaceuticals investors
Investor	Rounds
Jefferies	IPO
TCG Crossover	Series C
Guggenheim Securities	IPO
Pontifax Venture Capital	IPO
Vida Ventures	IPO, Series C
Deep Track Capital	IPO, Series C
TCG Crossover	IPO

View all Investors

LB Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

LB Pharmaceuticals Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersNew York City, New York

Employee Range49

Year Founded2015

Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.